Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
Immunity, Inflammation and Disease · 2023
DOI: 10.1002/iid3.853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Xierenguli Alimu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Myeloid-Derived Suppressor Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Galectin‐9 and myeloid‐derived suppressor cells (MDSCs) have an important role in tumors, but their clinical values in chronic lymphocytic leukemia (CLL) have not been fully elucidated. This study aimed to analyze the prognosis values of Galectin‐9 and MDSCs in CLL.
Methods
The concentrations of Galectin‐9, argininase‐1, and inducible nitric oxide synthase in serum were detected by enzyme‐linked immune sorbent assay. The expression of Tim‐3 protein in peripheral blood mononuclear cell was detected by Western blot. Flow cytometry was used to analyze the percentages of Tim‐3 on T‐cells (CD3 + T, CD4 + T, and CD8 + T cells) and MDSCs.
Results
Our results showed that Galectin‐9 and MDSCs significantly increased in CLL patients and were closely related to the disease progression. Patient's receiver operating characteristic, progression‐free survival, and Cox regression analysis showed that Galectin9 and MDSCs were poor prognostic factors of CLL.
Conclusion
Galectin‐9 and MDSCs were associated with clinical progression and could be important prognostic indicators for CLL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
- Senior Department of Hematology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
- CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, China.
- Hematology Institute of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
- Department of Immunology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.
ORCID-Profile: Xierenguli Alimu, Jianbing Ding
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Alimu, X., Zhang, J., Pang, N., Zhang, R., Chen, R., Zeng, X., Tudahong, S., Chen, G., Muhashi, M., Zhao, F., Ding, J., & Qu, J. (2023). Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.853
Vancouver
Alimu X, Zhang J, Pang N, Zhang R, Chen R, Zeng X, et al. Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.853
BibTeX
@article{Alimu2023,
author = {Alimu, Xierenguli and Zhang, Juan and Pang, Nannan and Zhang, Rui and Chen, Rong and Zeng, Xuejiao and Tudahong, Shabaaiti and Chen, Gang and Muhashi, Maliya and Zhao, Fang and Ding, Jianbing and Qu, Jianhua},
title = {Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia},
journal = {Immunity, Inflammation and Disease},
year = {2023},
doi = {10.1002/iid3.853}
}
EUVIMED